works great, with minimal to no side effects
Experiments on animals are still underway, so the multiple mechanisms of BPC-157 will still require further study
Policy The findings support continuing the use of GLP-1 medications in women with metabolic risk factors who are considering pregnancy, says Cara Dolin, MD, a maternal-fetal medicine specialist, and a coauthor of the research, which was presented at the Society of Maternal-Fetal Medicine pregnancy meeting in February 2026
[10] [11] This risk is relevant to retatrutide given its significant weight-loss effect, and patients should be aware of related symptoms (see 'When to Seek Medical Advice' below)
But this race is far from over
The guide on foods to avoid on tirzepatide covers dietary adjustments that help reduce gastrointestinal discomfort